ASX - By Stock
|
OSL |
Re:
Ann: Investor Update
|
|
vrs37
|
95 |
39K |
3 |
30/08/20 |
30/08/20 |
ASX - By Stock
|
95
|
39K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
vrs37
|
13K |
6.3M |
1 |
25/08/20 |
25/08/20 |
ASX - By Stock
|
13K
|
6.3M
|
1
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
vrs37
|
13K |
6.3M |
3 |
25/08/20 |
25/08/20 |
ASX - By Stock
|
13K
|
6.3M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
vrs37
|
13K |
6.3M |
2 |
24/08/20 |
24/08/20 |
ASX - By Stock
|
13K
|
6.3M
|
2
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
vrs37
|
13K |
6.3M |
1 |
24/08/20 |
24/08/20 |
ASX - By Stock
|
13K
|
6.3M
|
1
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
vrs37
|
13K |
6.3M |
2 |
24/08/20 |
24/08/20 |
ASX - By Stock
|
13K
|
6.3M
|
2
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
vrs37
|
13K |
6.3M |
2 |
24/08/20 |
24/08/20 |
ASX - By Stock
|
13K
|
6.3M
|
2
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
vrs37
|
13K |
6.3M |
3 |
24/08/20 |
24/08/20 |
ASX - By Stock
|
13K
|
6.3M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
vrs37
|
13K |
6.3M |
2 |
24/08/20 |
24/08/20 |
ASX - By Stock
|
13K
|
6.3M
|
2
|
|
ASX - By Stock
|
NOX |
Re:
EGM REVELATIONS
|
|
vrs37
|
2 |
1.5K |
5 |
22/08/20 |
22/08/20 |
ASX - By Stock
|
2
|
1.5K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
vrs37
|
13K |
6.3M |
6 |
22/08/20 |
22/08/20 |
ASX - By Stock
|
13K
|
6.3M
|
6
|
|
ASX - By Stock
|
OSL |
Re:
OSL Corpse
|
|
vrs37
|
49 |
20K |
1 |
15/08/20 |
15/08/20 |
ASX - By Stock
|
49
|
20K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
OSL Chart
|
|
vrs37
|
114 |
78K |
0 |
13/08/20 |
13/08/20 |
ASX - By Stock
|
114
|
78K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
OSL Corpse
|
|
vrs37
|
49 |
20K |
0 |
09/08/20 |
09/08/20 |
ASX - By Stock
|
49
|
20K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
OSL Corpse
|
|
vrs37
|
49 |
20K |
1 |
09/08/20 |
09/08/20 |
ASX - By Stock
|
49
|
20K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
What does Tocilizumab's COVID-19 trial failure mean for Biotron?
|
|
vrs37
|
61 |
22K |
0 |
08/08/20 |
08/08/20 |
ASX - By Stock
|
61
|
22K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
What does Tocilizumab's COVID-19 trial failure mean for Biotron?
|
|
vrs37
|
61 |
22K |
2 |
08/08/20 |
08/08/20 |
ASX - By Stock
|
61
|
22K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
What does Tocilizumab's COVID-19 trial failure mean for Biotron?
|
|
vrs37
|
61 |
22K |
4 |
08/08/20 |
08/08/20 |
ASX - By Stock
|
61
|
22K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
What does Tocilizumab's COVID-19 trial failure mean for Biotron?
|
|
vrs37
|
61 |
22K |
5 |
08/08/20 |
08/08/20 |
ASX - By Stock
|
61
|
22K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
What does Tocilizumab's COVID-19 trial failure mean for Biotron?
|
|
vrs37
|
61 |
22K |
2 |
08/08/20 |
08/08/20 |
ASX - By Stock
|
61
|
22K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
What does Tocilizumab's COVID-19 trial failure mean for Biotron?
|
|
vrs37
|
61 |
22K |
3 |
08/08/20 |
08/08/20 |
ASX - By Stock
|
61
|
22K
|
3
|
|
ASX - By Stock
|
OSL |
Re:
OSL Corpse
|
|
vrs37
|
49 |
20K |
0 |
07/08/20 |
07/08/20 |
ASX - By Stock
|
49
|
20K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
OSL Corpse
|
|
vrs37
|
49 |
20K |
0 |
07/08/20 |
07/08/20 |
ASX - By Stock
|
49
|
20K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
News: OSL Oncosil Medical Files For Registration Of Oncosiltm Device In U.S. Market
|
|
vrs37
|
28 |
10K |
0 |
07/08/20 |
07/08/20 |
ASX - By Stock
|
28
|
10K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
OSL Corpse
|
|
vrs37
|
49 |
20K |
0 |
07/08/20 |
07/08/20 |
ASX - By Stock
|
49
|
20K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
OSL Corpse
|
|
vrs37
|
49 |
20K |
1 |
05/08/20 |
05/08/20 |
ASX - By Stock
|
49
|
20K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
News: OSL Oncosil Medical Files For Registration Of Oncosiltm Device In U.S. Market
|
|
vrs37
|
28 |
10K |
0 |
03/08/20 |
03/08/20 |
ASX - By Stock
|
28
|
10K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
News: OSL Oncosil Medical Files For Registration Of Oncosiltm Device In U.S. Market
|
|
vrs37
|
28 |
10K |
2 |
03/08/20 |
03/08/20 |
ASX - By Stock
|
28
|
10K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Positive Top-Line Results in FSGS Phase 2a Clinical Study
|
|
vrs37
|
286 |
89K |
1 |
03/08/20 |
03/08/20 |
ASX - By Stock
|
286
|
89K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
News: OSL Oncosil Medical Files For Registration Of Oncosiltm Device In U.S. Market
|
|
vrs37
|
28 |
10K |
5 |
31/07/20 |
31/07/20 |
ASX - By Stock
|
28
|
10K
|
5
|
|
ASX - By Stock
|
OSL |
Re:
News: OSL Oncosil Medical Files For Registration Of Oncosiltm Device In U.S. Market
|
|
vrs37
|
28 |
10K |
5 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
28
|
10K
|
5
|
|
ASX - By Stock
|
OSL |
Re:
News: OSL Oncosil Medical Files For Registration Of Oncosiltm Device In U.S. Market
|
|
vrs37
|
28 |
10K |
2 |
29/07/20 |
29/07/20 |
ASX - By Stock
|
28
|
10K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
OSL Top Pick for FY21
|
|
vrs37
|
17 |
8.6K |
1 |
27/07/20 |
27/07/20 |
ASX - By Stock
|
17
|
8.6K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
OSL Top Pick for FY21
|
|
vrs37
|
17 |
8.6K |
1 |
25/07/20 |
25/07/20 |
ASX - By Stock
|
17
|
8.6K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
OSL Top Pick for FY21
|
|
vrs37
|
17 |
8.6K |
0 |
25/07/20 |
25/07/20 |
ASX - By Stock
|
17
|
8.6K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
OSL Top Pick for FY21
|
|
vrs37
|
17 |
8.6K |
0 |
24/07/20 |
24/07/20 |
ASX - By Stock
|
17
|
8.6K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
OSL Top Pick for FY21
|
|
vrs37
|
17 |
8.6K |
0 |
24/07/20 |
24/07/20 |
ASX - By Stock
|
17
|
8.6K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Data Shows Idronoxil Holds Key to Problem of COLD Cancers
|
|
vrs37
|
14 |
6.4K |
4 |
21/07/20 |
21/07/20 |
ASX - By Stock
|
14
|
6.4K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
vrs37
|
2.0K |
723K |
5 |
13/07/20 |
13/07/20 |
ASX - By Stock
|
2.0K
|
723K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
vrs37
|
2.0K |
723K |
4 |
13/07/20 |
13/07/20 |
ASX - By Stock
|
2.0K
|
723K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
vrs37
|
2.0K |
723K |
4 |
13/07/20 |
13/07/20 |
ASX - By Stock
|
2.0K
|
723K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Where are the COVID-19 results?
|
|
vrs37
|
91 |
34K |
0 |
08/07/20 |
08/07/20 |
ASX - By Stock
|
91
|
34K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
Where are the COVID-19 results?
|
|
vrs37
|
91 |
34K |
3 |
08/07/20 |
08/07/20 |
ASX - By Stock
|
91
|
34K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Where are the COVID-19 results?
|
|
vrs37
|
91 |
34K |
0 |
08/07/20 |
08/07/20 |
ASX - By Stock
|
91
|
34K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
Where are the COVID-19 results?
|
|
vrs37
|
91 |
34K |
0 |
08/07/20 |
08/07/20 |
ASX - By Stock
|
91
|
34K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
Where are the COVID-19 results?
|
|
vrs37
|
91 |
34K |
3 |
08/07/20 |
08/07/20 |
ASX - By Stock
|
91
|
34K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Where are the COVID-19 results?
|
|
vrs37
|
91 |
34K |
4 |
08/07/20 |
08/07/20 |
ASX - By Stock
|
91
|
34K
|
4
|
|
ASX - By Stock
|
OSL |
Re:
OSL Top Pick for FY21
|
|
vrs37
|
17 |
8.6K |
5 |
07/07/20 |
07/07/20 |
ASX - By Stock
|
17
|
8.6K
|
5
|
|
ASX - By Stock
|
OSL |
Re:
Investor Presentation
|
|
vrs37
|
126 |
49K |
1 |
06/07/20 |
06/07/20 |
ASX - By Stock
|
126
|
49K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil presents clinical data at ESMO World Congress
|
|
vrs37
|
12 |
4.4K |
1 |
03/07/20 |
03/07/20 |
ASX - By Stock
|
12
|
4.4K
|
1
|
|